Dallas 8/31/2010 10:17:46 PM
News / Business

NASDAQ Stock Movers on FDA Decision (OXBT, PSDV, HALO )

Stock Movers

Radient Pharmaceuticals Corporation (AMEX:RPC) climbed 3.31% to $0.775 on heavy volume after the company said it resumes collaborations with with Mayo Collaborative Services, Inc. in Onko-Sure IVD cancer test. The Test is to determine whether or not Onko-Sure is useful in CRC recurrence treatment monitoring.

Subscribe to daily free stock newsletter by visiting:  http://www.PennyStockPickReport.com

Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) climbed 3.90% to $3.20 on heavy volume after it announces positive results in DERMACYTE Oxygen Concentrate eight-week study.

According to the report: "At the conclusion of the study conducted with 36 women ages 39-63 with mild-to-moderate facial wrinkles, 80% of subjects experienced at least one-grade improvement on the Fitzpatrick Wrinkle Assessment Scale (FWAS) (P<0.0001); 97% experienced at least one grade of improvement compared to their baseline photos according to the investigator's Global Improvement Aesthetic Scale (GIAS) (P<0.0001); and 84% has at least a grade of improvement on their self-perception of GIAS (P<0.0001)."

PSivida Corp. (NASDAQ:PSDV) rose marginally to $3.26 after it announces that licensee Alimera Sciences (Nasdaq: ALIM) notified that Iluvien has been given Priority Review status by the U.S. FDA.

pSivida Corp., formerly pSivida Limited. develops drug delivery products that are administered by implantation, injection or insertion. Once administered, the drug is released on a controlled and level basis for months or years. The Company has developed with partners two of the only three products approved by the United States.

Halozyme Therapeutics, Inc. (NASDAQ:HALO)  jumped 1.25% to $7.28 on higher than the acerage volume after it completes root cause investigation regarding HYLENEX manufacturing and has identified a corrective action plan and regulatory strategy to reintroduce HYLENEX to the market.

Meeting materials are being finalized by Baxter (NYSE: BAX) and Halozyme for their U.S. FDA meeting.

About http://www.PennyStockPickReport.com

 

Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ NYSE stock exchange. Our subscribers receive daily up to date stock information on hot stocks, most active movers, top gainers, penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.